Balance Sheet: Liabilities and Stockholders’ Equity
Quarterly Data
The balance sheet provides creditors, investors, and analysts with information on company resources (assets) and its sources of capital (its equity and liabilities). It normally also provides information about the future earnings capacity of a company assets as well as an indication of cash flows that may come from receivables and inventories.
Liabilities represents obligations of a company arising from past events, the settlement of which is expected to result in an outflow of economic benefits from the entity.
Paying user area
Try for free
Gilead Sciences Inc. pages available for free this week:
- Analysis of Profitability Ratios
- Analysis of Long-term (Investment) Activity Ratios
- Enterprise Value to EBITDA (EV/EBITDA)
- Enterprise Value to FCFF (EV/FCFF)
- Price to FCFE (P/FCFE)
- Capital Asset Pricing Model (CAPM)
- Net Profit Margin since 2005
- Operating Profit Margin since 2005
- Return on Assets (ROA) since 2005
- Debt to Equity since 2005
The data is hidden behind: . Unhide it.
Get full access to the entire website from $10.42/mo, or
get 1-month access to Gilead Sciences Inc. for $24.99.
This is a one-time payment. There is no automatic renewal.
We accept:
Gilead Sciences Inc., consolidated balance sheet: liabilities and stockholders’ equity (quarterly data)
US$ in millions
Based on: 10-Q (reporting date: 2026-06-30), 10-Q (reporting date: 2026-03-31), 10-K (reporting date: 2025-12-31), 10-Q (reporting date: 2025-09-30), 10-Q (reporting date: 2025-06-30), 10-Q (reporting date: 2025-03-31), 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31).
A general contraction in the total liabilities and stockholders' equity base is observed over the analyzed period, with total liabilities and equity decreasing from 67,492 million USD in March 2021 to 49,362 million USD by June 2026. While the balance sheet showed relative stability through 2022, a more pronounced downward trend in total obligations and equity began to emerge in the later quarters of the sequence.
- Liability Structure and Debt Trends
- Total liabilities exhibit a gradual decline from 48,528 million USD in March 2021 to 37,618 million USD in June 2026. This reduction is primarily driven by a significant decrease in long-term liabilities, which fell from 38,823 million USD to 26,598 million USD over the same period. Long-term debt, net of the current portion, shows a fluctuating but generally downward trajectory, moving from 27,907 million USD in early 2021 to 23,832 million USD by mid-2026.
- Tax Liability Compression
- A substantial reduction is noted in tax-related obligations. Long-term income taxes payable declined sharply from 5,022 million USD in March 2021 to 943 million USD in June 2026. Similarly, deferred tax liabilities followed a consistent downward path, decreasing from 4,464 million USD to 333 million USD, indicating a significant shift in the company's long-term tax positioning.
- Current Liability Volatility
- Current liabilities demonstrate higher volatility compared to long-term obligations, peaking at 13,964 million USD in June 2023 before settling at 11,020 million USD in June 2026. Accrued rebates remained a significant component of current liabilities, generally trending upward from 3,369 million USD in March 2021 to a peak of 4,931 million USD in September 2025.
- Equity and Capital Changes
- Total stockholders' equity experienced a notable period of growth, peaking at 23,431 million USD in March 2026, before a sharp decline to 11,744 million USD in June 2026. This late-stage contraction is almost entirely attributable to a precipitous drop in retained earnings, which fell from 14,131 million USD in March 2026 to 2,200 million USD in June 2026, suggesting a substantial capital distribution event. Conversely, additional paid-in capital showed a consistent and steady increase throughout the entire period, rising from 4,092 million USD to 9,533 million USD.
The financial trajectory indicates a strategic reduction in long-term tax burdens and a gradual deleveraging of long-term debt. However, the significant volatility in retained earnings and the subsequent drop in total equity during the final quarter suggest a major reallocation of capital or a significant shareholder return initiative toward the end of the reported period.